The study aimed to compare in-hospital, 30-day and non-cancer-related 6-month death rates in a series of right and left pneumonectomy cases matched according to functional parameters.
INTRODUCTION
Despite improvements in operative techniques and postoperative care, pneumonectomy remains a high-risk procedure and has been associated with higher morbidity and mortality compared with other pulmonary resections [1] . In-hospital and 30-day mortality rates are normally reported as measures of the risk of the pneumonectomy, although a close follow-up of the patients allows us to observe that some of them are functionally impaired after the procedure [2] , experiencing different types of delayed postoperative complications.
Consequently, the usual indicators of postoperative mortality (30-day and in-hospital mortality) might not accurately reflect the risks of pneumonectomy. Treatment-related mortality should also include all deaths occurring as a direct or indirect consequence of the operation, whatever the delay from the surgical procedure may be. In that way, 90-day mortality has been used recently to emphasize the risks of pneumonectomy after induction chemotherapy in lung cancer patients, being considered as a more accurate parameter to ascertain the risk of pneumonectomy [3] .
The aims of this study were: (i) to compare 30-day and 6-month post-pneumonectomy mortality not related to cancer progression and (ii) to investigate whether right pneumonectomy encompasses a higher risk of delayed (6 month) non-cancerdependent mortality.
MATERIALS AND METHODS
We have studied a homogeneous population of lung cancer patients treated by pneumonectomy using a propensity score method for matching right and left pneumonectomy cases.
Studied population
This is a retrospective review of a prospectively recorded database of 263 consecutive non-small cell lung cancer lung cancer patients treated by scheduled pneumonectomy between January 1994 and April 2011. In 163 cases, surgery was performed on the left side and in the remaining 100 cases, on the right. During the same period of time, 1927 major anatomical lung resections were performed in the Department: 1614 patients underwent lobectomy (116 including sleeve resection procedures, 87 on the right side and 29 on the left. Of them, 10 included pulmonary artery sleeve resection on the right and 3 on the left side) and 375 pneumonectomy, 160 on the right side (14 sleeve right pneumonectomy) and 215 on the left (4 sleeve left pneumonectomy).
Perioperative management
Before surgery, all the patients were studied through an extensive work-up, which included physical examination, haematological and biochemical tests, electrocardiogram, chest X-rays, computed tomography (CT) scan of the chest as well as abdomen and bronchoscopy. Further image investigations were only performed if clinical findings or abnormal laboratory results suggested their indication.
Invasive mediastinal staging was not performed except in cases with mediastinal lymph nodes over 1 cm found at CT scan. positron emission tomography (PET)-CT scan, despite being routinely used today, was not available all through the study period. Starting 2007, PET scan was routinely indicated and Endobronchial Ultrasound (EBUS) indicated in cases with either PET positive at the mediastinum or PET negative and lymph nodes over 15 mm at CT scan.
Pulmonary function tests were indicated in all patients. For this study, we have reviewed only forced expiratory volume in the 1st second (FEV1) in absolute and percent values according to age, gender and height of the patient. Predicted postoperative FEV1% ( ppoFEV1%) was estimated in all cases according to the number of functional pulmonary segments to be removed. Diffusing capacity of the lung (DLCO) values have not been included in this investigation. Although currently DLCO measurement is mandatory in our settings before any anatomical resection, it was not at the beginning of the study.
All the patients with a previous history of cardiovascular disease or any suspicious changes in the electrocardiogram were referred for cardiologist assessment. As a rule, any relevant coronary stenosis was stented or by-passed before lung surgery.
Perioperative management was uniform for all cases during the study period, and it has been described elsewhere [4] . To summarize, all cases were operated on by the same team of senior thoracic surgeons. Anaesthesia procedures were indicated and performed or supervised by a senior cardiothoracic anaesthetist. Preoperative antibiotic regimen consisted of a unique dose of Cefuroxime 1500 mg that was repeated 6 h later if surgery continued. Careful management of intraoperative ventilation and fluid therapy was achieved. Extubation was performed in the operating room and, after a few hours in the recovery room, patients were transferred to the cardiothoracic ward. For postoperative analgesia, an epidural catheter was inserted and, bupivacaine and fentanyl were infused through it during the first 3 days, and followed by oral paracetamol and non-steroid anti-inflammatory drugs. Nursing care was also homogeneous in all cases and included incentive spirometry. Starting in 2002, a specific pre-and postoperative chest physiotherapy programme was implemented.
Definitions for each type of postoperative complications were agreed in advance by the team members, and all adverse events recorded at the patients' discharge. More specifically, a postoperative bronchial fistula was defined as any failure in the bronchial suture detected at bronchoscopy during the postoperative period. This included cases with bronchial dehiscence and pleural empyema requiring any surgical repair or thoracostomy, and cases with a pleural leakage detected in the immediate postoperative period resolved spontaneously with pleural drainage. All cases were staged according to the 6th edition of the TNM classification. Completeness and accuracy of all records were audited by a data manager before the discharge report was send to the patient or his referring physician. Patients were given a follow-up appointment in the outpatient clinic. Later on, phone contact either with the patient or with the patients' oncologist or referral physician was maintained and any changes in their basal status were recorded, including new hospital admissions, local or distant relapse of the disease, cardiopulmonary complications, adjuvant therapy, death date and its subsequent cause.
Data analysis
Variables in the study. The study included binary and continuous independent variables. Binary variables: gender, coronary or any other cardiac comorbidity, side of the pneumonectomy, induction chemotherapy, pathological lung cancer staging (I and II vs III and IV), bronchial fistula and occurrence of any other postoperative complication. Continuous variables: age of the patient, preoperative FEV1% and ppoFEV1%.
The dependent variable was death of the patient not related to local relapse or distant metastases of lung cancer at three different periods of time: during the hospitalization for surgery, and at 30 days and 6 months after pneumonectomy.
Propensity score-matched analysis. As we were aware that the different characteristics of our population of right and left pneumonectomy cases could have a direct effect on the results of our study, we decided to match our pneumonectomy cases according to functional parameters to obtain a quasiexperimental study using the propensity score methodology [5] . A propensity score was generated for all patients eligible and paired depending on whether they underwent either right or left pneumonectomy. The side of the pneumonectomy was the dependent variable, and the covariates were age, the presence of coronary artery disease (CAD), the presence of any other cardiac comorbidity and ppoFEV1%. A nearest-neighbour 1:1 matching method without replacement was used. Patients were stratified by propensity score groupings to evaluate the different mortality rates according to the side of the pneumonectomy. Preoperative values of the patients grouped were compared by standardized differences. After matching the cases, 89 pairs of cases were selected.
Estimation and comparison of the mortality rates. The prevalence of death at the three different periods was calculated for the whole series and for the matched cases. In the last, we calculated the odds ratio (OR) and its 95% confidence intervals (95% CIs) for in-hospital, 30-day and 6-month mortality in right and left pneumonectomies using the χ² test to assess the statistical significance of our results.
Logistic regression model and death hazard estimation.
Using the propensity-matched population, a logistic model was constructed to evaluate the influence of the side of the pneumonectomy, the age of the patient, the presence of bronchopleural fistula and the occurrence of any postoperative cardiorespiratory complications in the 6-month death hazard of the operated patients. A resampling bootstrap technique (with 500 replications) was used to increase the robustness of the model.
Graphic representation of death hazard on time series.
Death hazard calculated by the model was plotted on a time series and presented in a graph.
All mathematical calculations and graphics were performed using Stata/IC 12 (StataCorp, Texas, USA). Propensity scoring matching was performed using the Leuven and Sianesy Psmatch2 routine for Stata (http://fmwww.bc.edu/repec/bocode/ p/psmatch2.ado).
RESULTS
Between January 1994 and April 2011, 263 patients underwent pneumonectomy for lung cancer in our institution. Overall mortality in this series was as follows: in-hospital 7.9% (21 of 263); 30-day 10.6% (28 of 263) and 6-month mortality 22% (58 of 263). Eighteen cases were excluded from the study because their death was related to cancer relapse during the 6-month followup period (3 in-hospital deaths and 1 at 30 days due to undiagnosed brain metastases), and 14 patients died before 6 months due to cancer metastases (10 cases) or as a consequence of complications related to adjuvant chemotherapy (4 cases).
Our final population was formed by 245 patients; 155 (64%) underwent left and 90 (37%), right pneumonectomy. Clinical variables are shown in Tables 1 and 2 . Of these patients, 230 (94%) were men and 15 (6%) were women. In the preoperative work-up, 16 (7%) of the patients presented with CAD and 13 (5%) with another type of cardiac condition.
In the immediate postoperative period, 60 (24%) patients experienced some type of cardiorespiratory complication (including respiratory insufficiency, pneumonia, atelectasis of the remaining lung, cardiac insufficiency, atrial fibrillation, other cardiac dysrhythmias or coronary stroke). Of the 245 patients, 14 (6%) had some kind of bronchial fistula, including cases in which it was spontaneously closed.
In-hospital, 30-day and 6-month non-cancer-related mortality rates were 7.3 (3.9 in left cases and 13.3% in right cases), 9.8 (6.4 in left cases and 15.6% in right cases) and 16.3% (11.6 in left cases and 24.5% in right cases), respectively (40 cases in the whole series).
The propensity-matched score identified 89 pairs of comparable patients. In the matched population, mortality was as follows (Table 3) : 3 cases of in-hospital mortality in the left pneumonectomy group and 12 in the right pneumonectomy group (OR 4.5; 95% CI: 1.1-25.4, P = 0.01). Related to the 30-day mortality, 7 cases were identified in the left pneumonectomy group and 14 in the right pneumonectomy group (OR: 2.2; 95% CI: 0.8-6.7; P = 0.10). Finally, 11 cases of 6-month mortality were registered in the left pneumonectomy group and 22 in the right pneumonectomy group (OR: 2.3; 95% CI: 1.1-5.7; P = 0.032).
At logistic regression, only the following variables had a statistically significant influence on 6-month mortality: age (P = 0.001), right-sided pneumonectomy (P = 0.021) and the occurrence of any postoperative cardiorespiratory complications (P = 0.004) ( Table 4 ). IB  42  24  66  IIA  6  2  8  IIB  43  17  60  IIIA  30  21  51  IIIB  17  13  30  IV  5  5  10 Preoperative FEV1 (P = 0.973), ppoFEV1 (P = 0.790) and the occurrence of bronchial fistula were not statistically significant.
In Figure 1 , the 6-month death hazard for the patients having undergone both left and right pneumonectomies is presented. A significant (P = 0.03) increase in the risk of death after right pneumonectomy is noted.
DISCUSSION
Outcome measures of surgical quality have been widely used for benchmarking in thoracic surgery [6] and, along with some process measures, constitute the fundamentals of the European Society of Thoracic Surgeons (ESTS) accreditation of Thoracic Surgery units in Europe [7] . Among outcome measures, hospital mortality is easy to collect even from administrative databases [8] and it is the most widely used variable to consider when explaining to patients the risk of major surgery.
Defining operative mortality is not easy [9] and several definitions have been contemplated in the literature including any death occurring within 30 days after surgery, regardless of cause, in or out of the hospital (30-day mortality) and any death occurring 30 days to 6 months after surgery that was judged to be a direct result of a perioperative complication of the surgery (all procedure-related mortality) [10] . The relevance of reporting all mortality related to surgical procedures instead of in-hospital or 30-day mortality has been addressed by Edwards and Taylor in cardiac valve replacement [11] . These authors showed that 30-day mortality represents around half of the 365-day mortality for the procedure and commented on the convenience of considering all related mortality when discussing the acceptance of major surgery with patients. Accordingly, the majority of deaths after pneumonectomy occurred after discharge from the hospital. This fact has been shown by others in pneumonectomy patients receiving induction chemotherapy [3] , and it has been published that right pneumonectomy encompasses superior risk than left resection [12] , although this fact has not been confirmed by all [13] . In our series, only a minority of the cases received induction chemotherapy and induction radiotherapy was never indicated; thus, we cannot discuss the influence of preoperative therapy on long-term results. Nevertheless, we have found a consistent influence of right pneumonectomy on early and 6-month postoperative death. Chronic obstructive pulmonary disease has been associated with bad prognosis after lung cancer resection [14] , and it is also well known that intercurrent diseases and not lung cancer relapse are the most important causes of death in long-term survivors after pneumonectomy [15] . It could be hypothesized that the larger the amount of functional parenchyma amputated, the faster the functional patient's impairment and life expectancy decrease. This hypothesis has not been clearly demonstrated by our data since we could not find any correlation between ppoFEV1 values and 6-month risk of death. Unfortunately, we could not study the influence of DLCO values on long-term prognosis due to the lack of routine DLCO measurement in our cases before the last European Respiratory Society-ESTS guidelines publication [16] .
Right pneumonectomy has also been shown to have a higher risk of bronchial fistula, and this is a relevant factor influencing 30-day mortality [17] . In our cases, we could not find any association between bronchial stump failure and 6-month mortality, although we strongly agree that the prevalence of bronchial fistula is much higher in right-side pneumonectomy. Nevertheless, this investigation has not been focused on risk factor, prevention and therapy of this complication and the rates we have presented correspond to matched cases and not to the whole population of pneumonectomies performed in our hospital. The actual rate of bronchial fistula in our patients is 10% (16 of 160) on the right and 1.4% (3 of 215) on the left side (unpublished data). A different design would be necessary to validate our statements on the risk of death associated with bronchial fistula in the whole population.
Our in-hospital mortality is slightly higher than reported by the 2012 ESTS Annual Database Report [18] and comparable with that recently reported in the US [19] in General Thoracic Surgery teaching centres. Data are lacking in the literature to compare our reported 6-month mortality after pneumonectomy.
In conclusion, we have found that the risk of death after pneumonectomy increases with time and strongly depends on the side of the operation (it is higher after right pneumonectomy) and on the occurrence of any postoperative cardiorespiratory complication. These data could help to facilitate surgical decision analysis integrating clinical characteristics and patient's preferences after accurate information on the mid-term risks of the procedure [20] . On the other hand, our data cannot be generalized for hospital quality assessment since we lack accurate information on 6-month mortality in large databases and, besides, pneumonectomy is currently performed less frequently in the majority of centres, rendering it difficult to compare between different hospitals [21] .
APPENDIX. CONFERENCE DISCUSSION
Dr A. Turna (Istanbul, Turkey): You showed us a high mortality in the patients who underwent right pneumonectomy, and you stated that this mortality rate was not related to bronchopleural fistula. So what were the reasons for the high mortality and what do you think might be done to lower the incidence and the mortality rate?
Dr Rodriguez: What we have observed in our series is that all the patients, including those who developed bronchial fistula in the postoperative period, died due to cardiopulmonary complications, either directly or indirectly related to the procedure. Even with the six-month mortality rate, the cardiopulmonary complications had the greatest influence on the high death rate.
Dr Y. Colson (Boston, MA, USA): Have you thought about changing how you do preoperative testing? Did you think about PA occlusion testing, or something, to maybe better select these patients?
Dr Rodriguez: Sorry, could you repeat, please? Dr Colson: What have you thought about your preoperative selection if you are having these complications afterwards; you are having problems with their cardiac status, correct?
Dr Rodriguez: We select our patients according to the ESTS guidelines. When we started this study, the DLCO was not recorded for all the patients and maybe it would have been interesting to have included it as a variable, but we didn't have enough data. Indeed I think it is not an issue of the selection of the patients but rather an issue of the way the mortality and the complications are reported. Normally all of our patients, if we think they have any cardiological problems, are assessed by our cardiologists, and the pulmonary function tests are carefully reviewed. There is nothing more we could do to better select these patients. 
